BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 12055786)

  • 1. Immunoprophylaxis in tuberculosis.
    Aneja KS
    J Commun Dis; 1984 Mar; 16(1):49-53. PubMed ID: 12055786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research on BCG vaccination.
    ten Dam HG
    Adv Tuberc Res; 1984; 21():79-106. PubMed ID: 6433675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2006 Oct; 52(5):305-6. PubMed ID: 17008443
    [No Abstract]   [Full Text] [Related]  

  • 4. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calmette-Guerin (BCG) vaccination].
    Bonnaud F
    Rev Prat; 1996 Jun; 46(11):1362-7. PubMed ID: 8794620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of BCG vaccine strain on the immune response and protection against tuberculosis.
    Ritz N; Hanekom WA; Robins-Browne R; Britton WJ; Curtis N
    FEMS Microbiol Rev; 2008 Aug; 32(5):821-41. PubMed ID: 18616602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The success and failure of BCG - implications for a novel tuberculosis vaccine.
    Andersen P; Doherty TM
    Nat Rev Microbiol; 2005 Aug; 3(8):656-62. PubMed ID: 16012514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of some hypotheses related to the Chingelput bacille Calmette-Guérin trial.
    Smith D; Wiegeshaus E; Balasubramanian V
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S77-80. PubMed ID: 11010828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of BCG immunisation on tuberculin reactivity and booster effect in adults in a country with a high prevalence of tuberculosis.
    Hizel K; Maral I; Karakus R; Aktas F
    Clin Microbiol Infect; 2004 Nov; 10(11):980-3. PubMed ID: 15522000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BCG vaccination].
    Hutás I
    Orv Hetil; 1996 Mar; 137(12):619-22. PubMed ID: 8901354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
    Araujo Z; de Waard JH; de Larrea CF; Borges R; Convit J
    Vaccine; 2008 Oct; 26(44):5575-81. PubMed ID: 18723065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of BCG vaccination policy in Europe: 1994-96.
    Trnka L; Dankova D; Zitova J; Cimprichova L; Migliori GB; Clancy L; Zellweger JP
    Bull World Health Organ; 1998; 76(1):85-91. PubMed ID: 9615500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.
    Sierra VG
    Tuberculosis (Edinb); 2006; 86(3-4):169-78. PubMed ID: 16677860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
    Xing Z; Charters TJ
    Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update on the BGC vaccine. Indications for use in Europe and in developing countries].
    Guerin N; Levy-Bruhl D
    Med Trop (Mars); 1996; 56(2):173-6. PubMed ID: 8926881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the prevalence of tuberculosis infection in BCG vaccinated versus nonvaccinated school age children.
    Pulickal AS; Fernandez GV
    Indian Pediatr; 2007 May; 44(5):344-7. PubMed ID: 17536134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings.
    Manissero D; Lopalco PL; Levy-Bruhl D; Ciofi Degli Atti ML; Giesecke J
    Vaccine; 2008 Apr; 26(18):2253-9. PubMed ID: 18400344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present knowledge of immunization against tuberculosis.
    Dam HG; Toman K; Hitze KL; Guld J
    Bull World Health Organ; 1976; 54(3):255-69. PubMed ID: 798638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.